{
  "docId": "019de073-152c-71a8-85ee-4569efdf59ee",
  "docSlug": "7213c6821ef7b57b467d708a4eb22d62",
  "documentTitle": "Alkermes | Results Presentation Deck | 15 slides",
  "authorId": "alkermes",
  "authorName": "Alkermes",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 15,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 37,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-152c-71a8-85ee-4569efdf59ee/11",
  "deckHref": "/decks/019de073-152c-71a8-85ee-4569efdf59ee",
  "deckJsonHref": "/decks/019de073-152c-71a8-85ee-4569efdf59ee.json",
  "deckAnchorHref": "/decks/019de073-152c-71a8-85ee-4569efdf59ee#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.65,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Post-Launch TRx by Week",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "58572e2d-4cef-49d1-b3f3-7103bc2f540f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.75,
        "y": 0.3
      },
      "kind": "list",
      "text": "Q2’22 total TRx: ~17,000\n~4,260 prescribers had written a prescription for LYBALVI since launch",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4d6f034e-1798-4e20-839a-3bdf1d5d6c73",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.15,
        "x": 0.05,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "*Source: IQVIA NPA Weekly",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34c78ad9-7ac5-471a-91a3-9463cbc5a164",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.12
      },
      "kind": "title",
      "text": "LYBALVI® Prescription Growth Trends",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "09b4ae5e-dad6-4401-a7a6-0f1b40aafdf0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "5bc68a12-58d9-420e-8eab-b1101f843daf",
      "evidence": "Q2’22 total TRx: ~17,000 ~4,260 prescribers had written a prescription for LYBALVI since launch",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 11,
      "from": 4,
      "beatId": "f1bcf930-f5e7-4bd4-b57d-cf814f3523c2",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Financial Results Summary",
      "beatSlug": null,
      "evidence": "Slides 4-11 provide detailed overviews of financial results and product performance",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}